Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC

Clinical trial NCT06818097 · COMPLETED

Trial details

NCT number: NCT06818097
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: COMPLETED
Study type: OBSERVATIONAL

Advanced HCC Systemic Therapy Chemotherapy Immunotherapy Targeted Therapy Efficacy and Safety

Start date: 2021-10-01
Primary completion: 2025-04-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.